Magrolimab in Combination With Azacitidine for Patients With Untreated Higher-Risk Myelodysplastic Syndromes: 5F9005 Phase 1b Study Results

Sallman DA., Al Malki MM., Asch AS., Wang ES., Jurcic JG., Bradley TJ., Flinn IW., Pollyea DA., Kambhampati SN., Tanaka TN., Zeidner JF., Garcia-Manero G., Jeyakumar D., Gu L., Tan A., Chao M., O'Hear C., Lal I., Vyas P., Daver N.

Type

Conference paper

Publication Date

2022-01-01T00:00:00+00:00

Volume

97

Pages

S20 - S21

Permalink Close